Dissolution properties, solid-state transformation and polymorphic crystallization: progesterone case study-Reference-Cited by-同舟云学术

Dissolution properties, solid-state transformation and polymorphic crystallization: progesterone case study

Published:2013-09-13 Issue:7 Volume:19 Page:779-788
ISSN:1083-7450
Container-title:Pharmaceutical Development and Technology
language:en
Short-container-title:Pharmaceutical Development and Technology

Author:

Araya-Sibaja Andrea Mariela,Paulino Amarilis Scremin,Rauber Gabriela Schneider,Campos Carlos Eduardo Maduro,Cardoso Simone Gonçalves,Monti Gustavo Alberto,Heredia Valeria,Bianco Ismael,Beltrano Dante,Cuffini Silvia Lucia

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10837450.2013.829096

Reference29 articles.

1. Byrn S, Pfeiffer R, Stowell J. Solid-state chemistry of drugs. 2nd ed. Indiana: SSCI Inc.; 1999:574

2. Physical characterization of polymorphic drugs: an integrated characterization strategy

3. Development of Drug Substances as Mixture of Polymorphs: Studies to Control Form 3 in Casopitant Mesylate

4. The polymorphism of progesterone: Stabilization of a ‘disappearing’ polymorph by co‐crystallization

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering Long‐Releasing Hollow‐like or Condensed Progesterone Hormone Microcrystals with Controlled Polymorphism;Small Science;2024-05-26

2. Polymorphism characterization of segesterone acetate: A comprehensive study using XRPD, FT-IR and Raman spectroscopy;International Journal of Pharmaceutics;2021-03

3. Solubility determination and thermodynamic modelling of Progesterone in twelve pure solvents and three binary solvents at 278.15 to 323.15 K;Journal of Molecular Liquids;2021-02

4. Controlled-Release from High-Loaded Reservoir-Type Systems—A Case Study of Ethylene-Vinyl Acetate and Progesterone;Pharmaceutics;2020-01-28

5. The Polymorphism of Drugs: New Approaches to the Synthesis of Nanostructured Polymorphs;Pharmaceutics;2020-01-01